Results 231 to 240 of about 5,302,367 (265)

RETRACTION: The PI3K/mTOR Dual Inhibitor NVP‐BEZ235 Stimulates Mutant p53 Degradation to Exert Anti‐Tumor Effects on Triple‐Negative Breast Cancer Cells

FEBS Open Bio, EarlyView.
RETRACTION: J. Cai, J. Xia, J. Zou, Q. Wang, Q. Ma, R. Sun, H. Liao, L. Xu, D. Wang, and X. Guo, “The PI3K/mTOR Dual Inhibitor NVP‐BEZ235 Stimulates Mutant p53 Degradation to Exert Anti‐Tumor Effects on Triple‐Negative Breast Cancer Cells,” FEBS Open Bio 10, no. 4 (2020): 535–545, https://doi.org/10.1002/2211‐5463.12806.
wiley   +1 more source

Some of the next articles are maybe not open access.

Related searches:

Global Cancer Statistics 2020: GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 Countries

Ca-A Cancer Journal for Clinicians, 2021
Hyuna Sung, Jacques Ferlay, Rebecca L Siegel   +2 more
exaly  

Cancer Statistics, 2021

Ca-A Cancer Journal for Clinicians, 2021
Rebecca L Siegel, Kimberly D Miller
exaly  

Cancer statistics, 2022

Ca-A Cancer Journal for Clinicians, 2022
Rebecca L Siegel, Kimberly D Miller, Ahmedin Jemal Dvm   +2 more
exaly  

Cancer statistics, 2023

Ca-A Cancer Journal for Clinicians, 2023
Rebecca L Siegel, Kimberly D Miller, Nikita Sandeep Wagle   +2 more
exaly  

FROM THE EDITORS

Bioethics, 2002
Ruth Chadwick, Udo Schüklenk
openaire   +1 more source

From the Editor

Family & Community Health, 1999
openaire   +5 more sources

From the editors' desk

IEEE Electrical Insulation Magazine, 2004
J. Densley, L. Audrieth
openaire   +1 more source